Cephalon Acquires Generic Drug maker Mepha
Taskin Ahmed
Abstract
US biopharma company Cephalon acquired the Swiss-based generic pharmaceutical company Mepha AG for US$590 M thereby throwing open the doors to markets in Europe, Africa and the Middle East.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.